Skip to main content

Animations

MJFF Publications

1581 - 1590 of 8808 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: Neural correlates of risky decision making in Parkinson’s disease patients with impulse control disorders
    Journal Name: Experimental Brain Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00221-022-06423-6
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Neurofilament light levels predict clinical progression and death in multiple system atrophy
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awac253
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Older patients with COVID‐19 and neuropsychiatric conditions: A study of risk factors for mortality
    Journal Name: Brain and Behavior
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/brb3.2787
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Interfacility Transfers for Seizure-Related Emergencies in the United States
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000201319
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Shared molecular genetic factors influence subcortical brain morphometry and Parkinson’s disease risk
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00515-y
    Citation Count: 12
  • Summary Details
    OPEN
    Title: A pesticide and iPSC dopaminergic neuron screen identifies and classifies Parkinson-relevant pesticides
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-023-38215-z
    Citation Count: 65
  • Summary Details
    OPEN
    Title: Need for personalized monitoring of Parkinson’s disease: the perspectives of patients and specialized healthcare providers
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2023.1150634
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Golgi-IP, a tool for multimodal analysis of Golgi molecular content
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2219953120
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Acid ceramidase involved in pathogenic cascade leading to accumulation of α-synuclein in iPSC model ofGBA1-associated Parkinson’s disease
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/hmg/ddad025
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Parkinson’s disease population-wide registries in the United States: Current and future opportunities
    Journal Name: Frontiers in Digital Health
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fdgth.2023.1149154
    Citation Count: 4
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.